Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Vaccine ; 37(30): 4094-4102, 2019 07 09.
Article in English | MEDLINE | ID: mdl-31178378

ABSTRACT

Murine antisera with neutralising activity for the coronavirus causative of Middle East respiratory syndrome (MERS) were induced by immunisation of Balb/c mice with the receptor binding domain (RBD) of the viral Spike protein. The murine antisera induced were fully-neutralising in vitro for two separate clinical strains of the MERS coronavirus (MERS-CoV). To test the neutralising capacity of these antisera in vivo, susceptibility to MERS-CoV was induced in naive recipient Balb/c mice by the administration of an adenovirus vector expressing the human DPP4 receptor (Ad5-hDPP4) for MERS-CoV, prior to the passive transfer of the RBD-specific murine antisera to the transduced mice. Subsequent challenge of the recipient transduced mice by the intra-nasal route with a clinical isolate of the MERS-CoV resulted in a significantly reduced viral load in their lungs, compared with transduced mice receiving a negative control antibody. The murine antisera used were derived from mice which had been primed sub-cutaneously with a recombinant fusion of RBD with a human IgG Fc tag (RBD-Fc), adsorbed to calcium phosphate microcrystals and then boosted by the oral route with the same fusion protein in reverse micelles. The data gained indicate that this dual-route vaccination with novel formulations of the RBD-Fc, induced systemic and mucosal anti-viral immunity with demonstrated in vitro and in vivo neutralisation capacity for clinical strains of MERS-CoV.


Subject(s)
Antibodies, Neutralizing/immunology , Antibodies, Neutralizing/metabolism , Middle East Respiratory Syndrome Coronavirus/immunology , Middle East Respiratory Syndrome Coronavirus/pathogenicity , Animals , Antibodies, Viral/immunology , Antibodies, Viral/metabolism , Dipeptidyl Peptidase 4/genetics , Dipeptidyl Peptidase 4/metabolism , Disease Models, Animal , Female , Immunity, Mucosal/physiology , Lung/immunology , Lung/metabolism , Lung/virology , Mice , Mice, Inbred BALB C , Spike Glycoprotein, Coronavirus/immunology , Vaccination/methods , Viral Load
2.
J Virol Methods ; 177(1): 123-7, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21762730

ABSTRACT

Understanding the ability to survive in an aerosol leads to better understanding of the hazard posed by pathogenic organisms and can inform decisions related to the control and management of disease outbreaks. This basic survival information is sometimes lacking for high priority select agents such as the filoviruses which cause severe disease with high case fatality rates and can be acquired through the aerosol route. Microthreads in the form of spiders' webs were used to capture aerosolised filoviruses, and the decay rates of Zaire ebolavirus and Marburgvirus were determined. Results were compared to data obtained using a Goldberg drum to measure survival as a dynamic aerosol. The two methods of obtaining aerostability information are compared.


Subject(s)
Ebolavirus/physiology , Marburgvirus/physiology , Aerosols , Animals , Chlorocebus aethiops , Filoviridae Infections/epidemiology , Filoviridae Infections/transmission , Filoviridae Infections/virology , Humans , Microbial Viability , Spiders/virology , Vero Cells , Virology/methods
3.
J Appl Microbiol ; 109(5): 1531-9, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20553340

ABSTRACT

AIMS: Filoviruses are associated with high morbidity and lethality rates in humans, are capable of human-to-human transmission, via infected material such as blood, and are believed to have low infectious doses for humans. Filoviruses are able to infect via the respiratory route and are lethal at very low doses in experimental animal models, but there is minimal information on how well the filoviruses survive within aerosol particles. There is also little known about how well filoviruses survive in liquids or on solid surfaces which is important in management of patients or samples that have been exposed to filoviruses. METHODS AND RESULTS: Filoviruses were tested for their ability to survive in different liquids and on different solid substrates at different temperatures. The decay rates of filoviruses in a dynamic aerosol were also determined. CONCLUSIONS: Our study has shown that Lake Victoria marburgvirus (MARV) and Zaire ebolavirus (ZEBOV) can survive for long periods in different liquid media and can also be recovered from plastic and glass surfaces at low temperatures for over 3 weeks. The decay rates of ZEBOV and Reston ebolavirus (REBOV) plus MARV within a dynamic aerosol were calculated. ZEBOV and MARV had similar decay rates, whilst REBOV showed significantly better survival within an aerosol. SIGNIFICANCE AND IMPACT OF THE STUDY: Data on the survival of two ebolaviruses are presented for the first time. Extended data on the survival of MARV are presented. Data from this study extend the knowledge on the survival of filoviruses under different conditions and provide a basis with which to inform risk assessments and manage exposure to filoviruses.


Subject(s)
Aerosols , Ebolavirus/physiology , Environmental Microbiology , Marburgvirus/physiology , Microbial Viability , Animals , Culture Media , Glass , Guinea Pigs , Plastics , Serum/virology , Time Factors
4.
Int J Antimicrob Agents ; 27(5): 439-43, 2006 May.
Article in English | MEDLINE | ID: mdl-16621457

ABSTRACT

The efficacies of gatifloxacin and moxifloxacin were assessed in a BALB/c mouse model of pneumonic tularemia and compared with the efficacy of ciprofloxacin. The rate of relapse following dexamethasone treatment was also investigated. Mice were given 100 mg/kg of the antibiotic by oral administration twice daily for 14 days following an aerosol challenge. All three fluoroquinolones prevented disease during the treatment period, but significant failure rates occurred after the cessation of therapy. Both gatifloxacin and moxifloxacin were more effective than ciprofloxacin at reducing late mortality. Fluoroquinolones may therefore be considered useful candidates for the treatment of pneumonic tularemia.


Subject(s)
Aza Compounds/therapeutic use , Ciprofloxacin/therapeutic use , Fluoroquinolones/therapeutic use , Pneumonia, Bacterial/drug therapy , Quinolines/therapeutic use , Tularemia/drug therapy , Animals , Anti-Bacterial Agents/therapeutic use , Female , Gatifloxacin , Mice , Mice, Inbred BALB C , Moxifloxacin
5.
J Antimicrob Chemother ; 56(6): 1069-73, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16223941

ABSTRACT

OBJECTIVES: The in vivo efficacy of ciprofloxacin, gatifloxacin and moxifloxacin were assessed in an experimental Francisella tularensis Schu S4 infection in the BALB/c mouse model. METHODS: Mice were given 100 mg/kg of antibiotic by oral administration twice daily commencing at 6, 24 or 48 h post-exposure and continued for 14 days post-exposure. All mice were challenged subcutaneously with 1 x 10(6) cfu F. tularensis Schu S4 and observed for a period of 56 days. RESULTS: Treatment initiated 6 h post-exposure resulted in 94, 100 and 100% survival for ciprofloxacin, gatifloxacin and moxifloxacin, respectively. When treatment was delayed until 24 h post-exposure the survival rates were ciprofloxacin 67%, gatifloxacin 96% and moxifloxacin 100%. Treatment initiated at 48 h post-exposure resulted in a significant reduction in the survival rate of the ciprofloxacin-treated mice, with 0% survival compared with 84 and 62% for gatifloxacin and moxifloxacin, respectively. Non-treated infected control mice died within 96 h post-exposure. Dexamethasone given at day 42 for 7 days to suppress the animals' immune system caused relapse in all of the treatment groups. CONCLUSIONS: Both gatifloxacin and moxifloxacin were more effective at preventing mortality than ciprofloxacin and could be considered as alternative antibiotics in the treatment of systemic F. tularensis infection.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Aza Compounds/therapeutic use , Ciprofloxacin/therapeutic use , Fluoroquinolones/therapeutic use , Francisella tularensis/drug effects , Quinolines/therapeutic use , Tularemia/drug therapy , Administration, Oral , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Aza Compounds/administration & dosage , Aza Compounds/pharmacology , Ciprofloxacin/administration & dosage , Ciprofloxacin/pharmacology , Colony Count, Microbial , Dexamethasone/administration & dosage , Disease Models, Animal , Female , Fluoroquinolones/administration & dosage , Fluoroquinolones/pharmacology , Gatifloxacin , Mice , Mice, Inbred BALB C , Moxifloxacin , Quinolines/administration & dosage , Quinolines/pharmacology , Survival Analysis , Tularemia/mortality , Tularemia/pathology
6.
J Antimicrob Chemother ; 55(4): 523-7, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15731198

ABSTRACT

OBJECTIVES: To compare the efficacy of moxifloxacin, gatifloxacin and ciprofloxacin for the post-exposure prophylaxis and treatment of experimental Burkholderia pseudomallei infection. The presence of persistent infection in treated animals and the rate of relapse following dexamethasone treatment were also investigated. METHODS: BALB/c mice were inoculated subcutaneously with 1.75 x 10(6) cfu of B. pseudomallei strain 576. Gatifloxacin, moxifloxacin and ciprofloxacin (100 mg/kg) were given orally at 12 hourly intervals for 14 days starting at 6 h, 7 days or 12 days post-challenge. Control mice did not receive antibiotic therapy. RESULTS: No regimen gave 100% protection. Prophylaxis was most effective when started 6 h post-challenge, with survival rates at 42 days for ciprofloxacin, gatifloxacin and moxifloxacin being 58%, 75% and 75%, respectively. For treatment started at day 7 post-challenge, survival rates were 17%, 11% and 44%, respectively. When antibiotic treatment was delayed until day 12 post-challenge, survival rates fell to 21%, 17% and 28%, respectively. Following dexamethasone treatment of survivors at 42 days post-challenge, relapses occurred in all treatment groups. CONCLUSIONS: Fluoroquinolones do not provide good post-exposure protection against infection with B. pseudomallei. The newer agents moxifloxacin and gatifloxacin are not significantly better than ciprofloxacin for this purpose.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Fluoroquinolones/therapeutic use , Melioidosis/prevention & control , Animals , Aza Compounds/therapeutic use , Ciprofloxacin/therapeutic use , Dexamethasone/pharmacology , Drug Administration Schedule , Female , Gatifloxacin , Glucocorticoids/pharmacology , Mice , Mice, Inbred BALB C , Moxifloxacin , Quinolines/therapeutic use
7.
Int J Antimicrob Agents ; 24(6): 609-12, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15555886

ABSTRACT

The efficacies of prophylactic and therapeutic gatifloxacin and moxifloxacin were assessed in a BALB/c mouse model of systemic and pneumonic plague and compared with ciprofloxacin. Mice were given 100 mg/kg of the antibiotic by oral administration twice daily for 7 days starting 1h prior to infection or following infection. All antibiotics offered full protection for up to 6h following systemic challenge, and for up to 30 h following an aerosol challenge. The efficacy of each of the antibiotics decreased when antibiotics were started 18 h following systemic challenge and 48 h following aerosol challenge. Fluoroquinolones may therefore be considered useful candidates for the treatment of bubonic and pneumonic plague.


Subject(s)
Fluoroquinolones/pharmacology , Fluoroquinolones/therapeutic use , Plague/drug therapy , Yersinia pestis/drug effects , Animals , Ciprofloxacin/pharmacology , Ciprofloxacin/therapeutic use , Disease Models, Animal , Fluoroquinolones/pharmacokinetics , Gatifloxacin , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests , Plague/microbiology , Plague/prevention & control
8.
J Antimicrob Chemother ; 54(1): 95-9, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15163650

ABSTRACT

OBJECTIVES: To compare the fluoroquinolones gatifloxacin and moxifloxacin with ciprofloxacin for post-exposure prophylaxis of systemic anthrax in a BALB/c mouse model. METHODS: Treated mice and controls were inoculated subcutaneously with 5 x 10(4) spores/mouse of Bacillus anthracis Ames strain and observed for 37 days after challenge. Treated mice were given 100 mg/kg of antibiotic orally twice daily for 14 days, starting at various times post-challenge. RESULTS: Treatment starting 6 h post-challenge resulted in survival rates of 90%, 15% and 40% for gatifloxacin, moxifloxacin and ciprofloxacin, respectively. Treatment commencing 24 h post-challenge resulted in survival rates of 65%, 10% and 5%, respectively. Treatment starting more than 24 h after exposure had little effect on survival. CONCLUSIONS: Gatifloxacin appeared to be more effective than moxifloxacin or ciprofloxacin, at similar doses, for early post-exposure treatment of murine systemic anthrax. However, these results might be due to differences in potency or pharmacokinetic properties.


Subject(s)
Anthrax/prevention & control , Anti-Infective Agents/therapeutic use , Fluoroquinolones/therapeutic use , Animals , Anthrax/microbiology , Anti-Infective Agents/pharmacokinetics , Aza Compounds/pharmacokinetics , Aza Compounds/therapeutic use , Bacillus anthracis/drug effects , Ciprofloxacin/pharmacokinetics , Ciprofloxacin/therapeutic use , Female , Fluoroquinolones/pharmacokinetics , Gatifloxacin , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests , Moxifloxacin , Quinolines/pharmacokinetics , Quinolines/therapeutic use , Survival Analysis
9.
Vet Microbiol ; 80(3): 213-26, 2001 Jun 06.
Article in English | MEDLINE | ID: mdl-11337137

ABSTRACT

In order to develop a model of Mycobacterium bovis infection with pathogenetical relevance, a modified version of the Henderson apparatus was used to deliver infectious aerosols directly to the snouts of guinea pigs. Aerosols generated from 10(6), 10(7), 10(8)CFU/ml M. bovis suspensions established disease in every animal, with estimated retained doses of 10, 100, 1000 CFU, respectively. For comparison, other guinea pigs were inoculated with 100 CFU M. bovis intramuscularly (i.m.). Pathology and bacterial colonisation of lungs and spleen varied according to the dose and route of inoculation. Animals inoculated i.m. gave a significant cutaneous tuberculin hypersensitivity reaction earlier after testing than those infected aerogenically. A serological response to M. bovis antigens was detected in all infected animals. Intensity of antigen recognition was dose-dependent and although the range of antigens recognised varied between animals, a 25 kDa antigen present in the cell fraction was serodominant. Thus, a reproducible guinea pig model has been defined that may be suitable for virulence, vaccination, and immunological studies.


Subject(s)
Disease Models, Animal , Mycobacterium bovis , Tuberculosis, Bovine/microbiology , Administration, Intranasal , Animals , Antibodies, Bacterial/blood , BCG Vaccine/immunology , Blotting, Western/veterinary , Cattle , Female , Guinea Pigs , Hypersensitivity, Delayed/microbiology , Hypersensitivity, Delayed/veterinary , Injections, Intramuscular/veterinary , Lung/microbiology , Lung/pathology , Mycobacterium bovis/immunology , Mycobacterium bovis/pathogenicity , Skin Tests/veterinary , Spleen/microbiology , Tuberculosis, Bovine/immunology
10.
Lett Appl Microbiol ; 31(3): 238-41, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10972736

ABSTRACT

Tuberculosis is transmitted primarily by the aerosol route and the aim of this study was to measure the ability of pathogenic mycobacteria to survive in aerosols generated from artificial saliva. Aerosols of Mycobacterium avium, Mycobacterium intracellulare and Mycobacterium tuberculosis were generated and maintained in air under controlled conditions using a Henderson apparatus and a rotating drum. There were no differences in aerosol survival between the three species, and all had a poor survival rate over a period of 1 h. These data confirm epidemiological studies that close and prolonged contact with a TB patient is required for transmission of infection.


Subject(s)
Air Microbiology , Mycobacterium avium Complex/growth & development , Mycobacterium tuberculosis/growth & development , Aerosols , Colony Count, Microbial , Particle Size , Saliva/microbiology , Sodium Chloride
11.
Vaccine ; 16(8): 810-7, 1998 May.
Article in English | MEDLINE | ID: mdl-9627938

ABSTRACT

The efficacy of recombinant Bacillus anthracis Protective Antigen (rPA) produced in Bacillus subtilis and formulated in Alhydrogel or MPL-TDM-CWS (Ribi adjuvant) has been tested and compared to the licensed UK human vaccine in guinea pigs challenged by the aerosol route with the Ames strain of B. anthracis. rPA combined with the Ribi adjuvant was found to be the only formulation to provide 100% protection from challenge. Analysis of immunological parameters in the individual animals revealed significant differences between the rPA/Ribi vaccine group and rPA/Alhydrogel and human vaccine groups for antigen specific lymphocyte proliferation, PA neutralisation and antigen specific IgG2 levels, but indicated no significant differences in PA-specific IgG1 levels. rPA formulated in Alhydrogel induced a mainly IgG1 response whilst the rPA/Ribi vaccine produced a predominantly IgG2 response.


Subject(s)
Anthrax/prevention & control , Bacillus anthracis/immunology , Adjuvants, Immunologic , Aerosols , Aluminum Hydroxide/pharmacology , Animals , Anthrax/immunology , Antibodies, Bacterial/biosynthesis , Cell Wall Skeleton/pharmacology , Cord Factors/pharmacology , Evaluation Studies as Topic , Female , Guinea Pigs , Immunity, Cellular/drug effects , Immunoglobulin G/biosynthesis , Immunoglobulin G/immunology , Lipid A/analogs & derivatives , Lipid A/pharmacology , Lung/immunology , Lung/microbiology , Lymphocyte Activation , Macrophage Activation , Male , Spores, Bacterial
12.
Lett Appl Microbiol ; 23(5): 347-9, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8987717

ABSTRACT

Airborne cross-infection by Salmonella enteritidis PT4 strains was demonstrated between sets of orally infected 1-d-old chicks and identical uninfected control chicks. Low numbers of Salm. enteritidis were detected in the air of the rooms housing the chicks. Sentinel mice within the rooms did not become infected. This study demonstrates that low levels of airborne Salm. enteritidis are a potential source of cross-infection in poultry houses.


Subject(s)
Air Microbiology , Chickens/microbiology , Poultry Diseases/transmission , Salmonella Infections, Animal/transmission , Salmonella enteritidis , Animals , Mice
14.
Lett Appl Microbiol ; 23(2): 107-9, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8987450

ABSTRACT

Small particle aerosols of plate-grown Salmonella enteritidis and Salm. typhimurium were generated and maintained within a rotating drum at 75% relative humidity and 24 degrees C for 2 h. Plate-grown organisms were found to be more aerosol-stable than broth-grown organisms. Differences were observed between the two species; plate-grown Salm. typhimurium retained 100% viability after 2 h compared to approximately 70% for plate-grown Salm. enteritidis. A large proportion of cells of both serotypes remained viable in aerosols after 2 h, confirming the potential for airborne transmission for these organisms, e.g. within henhouses and during food processing.


Subject(s)
Aerosols/adverse effects , Colony Count, Microbial , Salmonella enteritidis/physiology , Salmonella typhimurium/physiology , Bacteriological Techniques , Salmonella enteritidis/growth & development , Salmonella enteritidis/pathogenicity , Salmonella typhimurium/growth & development , Salmonella typhimurium/pathogenicity
15.
Epidemiol Infect ; 117(1): 79-88, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8760953

ABSTRACT

Two Enteritidis PT4 isolates which differed in inherent tolerance to heat, acid, H2O2 and the ability to survive on surfaces were used to infect mice, day-old chicks or laying hens. The acid-, heat-, H2O2- and surface-tolerant isolate was more virulent in mice and more invasive in laying hens, particularly in reproductive tissue. However, no significant differences were observed in behaviour in chicks. Both PT4 isolates were able to infect chicks housed in the same room as infected birds, although the heat-tolerant isolate survived significantly better than the heat-sensitive one in aerosols.


Subject(s)
Acids , Hot Temperature , Salmonella Infections, Animal/microbiology , Salmonella enteritidis/pathogenicity , Animals , Chickens , Colony Count, Microbial , Eggs/microbiology , Female , Humans , Mice , Mice, Inbred C57BL , Salmonella enteritidis/growth & development , Species Specificity , Virulence
16.
J Infect ; 30(1): 13-6, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7751659

ABSTRACT

To study and develop the urinary antigen detection assay, urine was obtained from aerosol infected guinea pigs. The appearance of Legionella pneumophila antigen in guinea pig urine was then compared with that detected in urine from human Legionnaires' Disease (LD) cases. This study demonstrated that the antigen expressed in the experimental model of LD was of identical molecular weight, reacted almost identically in an ELISA based assay and in Western blots with the antigen found in human urine. The guinea pig urine can therefore be used as a reliable, consistent and controllable source of antigen for use in the urinary antigen assay.


Subject(s)
Antigens, Bacterial/isolation & purification , Antigens, Bacterial/urine , Legionella pneumophila/immunology , Legionnaires' Disease/urine , Animals , Antigens, Bacterial/immunology , Blotting, Western , Chromatography, Gel , Enzyme-Linked Immunosorbent Assay , Guinea Pigs , Humans , Legionella pneumophila/classification , Legionnaires' Disease/immunology
17.
Epidemiol Infect ; 112(1): 69-79, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8119366

ABSTRACT

Aerosol infection (AI) of Porton outbred mice with Listeria species, exhibiting varying degrees of virulence, was compared with gastric intubation (GI) on the basis of numbers of deaths, 50% lethal dose (LD50) and pattern of listerial infection. The AI route appeared to be more sensitive, efficient and consistent than GI in that it required 10(5) fewer micro-organisms to obtain infection and death then ensued within 4 days, with GI deaths usually occurring on day 7. All the virulent strains tested caused 100% mortality by AI, while virulent and avirulent strains were indistinguishable by GI. Bacterial counts in the livers and spleens of infected mice were consistent with the relative virulence of the infectious agent using AI but not in GI mice. There were higher numbers of micro-organisms and more widespread lesions in the organs of AI mice than in GI. Results indicate that AI is an accurate in vivo indicator of virulence in listeria and using AI, bacterial counts in the liver and spleen could replace LD50 tests, thereby reducing the number of animals required for in vivo virulence testing.


Subject(s)
Listeria/pathogenicity , Listeriosis/etiology , Aerosols , Animals , Bacteremia/microbiology , Brain/microbiology , Humans , Intubation, Gastrointestinal , Kidney/microbiology , Lethal Dose 50 , Listeriosis/microbiology , Liver/microbiology , Lung/microbiology , Mice , Spleen/microbiology , Stomach/microbiology , Trachea/microbiology , Virulence
18.
FEMS Microbiol Lett ; 107(1): 5-9, 1993 Feb 15.
Article in English | MEDLINE | ID: mdl-8467999

ABSTRACT

To better define the antigenic structure of the outer cell membranes of Legionellae, a panel of 6 monoclonal antibodies was raised against partially purified outer membranes of Legionella pneumophila serogroup 1, Corby strain. This study describes the purification and characterization of one of these monoclonal antibodies reacting with a 135-kDa protein, which was shown to be common to all 14 serogroups of Legionella pneumophila. It shows no cross-reactivity with 20 other Legionella species, or 9 other Gram-negative species tested by SDS-PAGE and Western blotting procedures. The epitope would appear to be predominantly surface exposed and, from preliminary detergent extraction studies, not peptidoglycan-associated.


Subject(s)
Antibodies, Bacterial/immunology , Antibodies, Monoclonal/immunology , Antigens, Bacterial/immunology , Bacterial Outer Membrane Proteins/immunology , Legionella pneumophila/immunology , Animals , Antibodies, Bacterial/biosynthesis , Antibodies, Monoclonal/biosynthesis , Blotting, Western , Cross Reactions , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Gram-Negative Bacteria/immunology , Mice , Mice, Inbred BALB C/immunology , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL